Literature DB >> 3805724

Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

W J Ming, L Bersani, A Mantovani.   

Abstract

Human recombinant tumor necrosis factor (TNF) induced migration across polycarbonate and nitrocellulose filters of human peripheral blood monocytes and polymorphonuclear leukocytes, TNF was active in inducing migration at concentrations less than 1 U/ml, and maximal responses (observed at greater than 100 U/ml) were comparable to those elicited by standard reference chemoattractants (FMLP, 10 nM; activated human serum, 5%). Checkerboard analysis performed by seeding different concentrations of TNF above and below the filter revealed that maximal induction of migration required a positive concentration gradient between the lower and upper compartments and that TNF elicited an actual chemotactic response in phagocytes. An anti-TNF rabbit antiserum and anti-TNF mouse monoclonal antibody abolished the chemotactic activity of TNF. Recombinant lymphotoxin was also chemotactic for phagocytes, and its activity was blocked by an anti-lymphotoxin antiserum. Human umbilical vein endothelial cells and blood large granular lymphocytes did not respond chemotactically to TNF under conditions in which appropriate reference chemoattractants were active. The chemotactic activity of TNF may serve to recruit phagocytic cells from the blood compartment to amplify resistance against noxious agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805724

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  134 in total

1.  Identification and characterization of macrophage inflammatory protein 2.

Authors:  S D Wolpe; B Sherry; D Juers; G Davatelis; R W Yurt; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Tumour necrosis factor-alpha in infectious meningitis.

Authors:  D Nadal; D Leppert; K Frei; P Gallo; H Lamche; A Fontana
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

3.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

4.  Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration.

Authors:  P Miossec; D Cavender; M Ziff
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

5.  Human tumor necrosis factor increases the resistance against Listeria infection in mice.

Authors:  K Kato; A Nakane; T Minagawa; N Kasai; K Yamamoto; N Sato; N Tsuruoka
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

Review 6.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation.

Authors:  L Dejager; K Dendoncker; M Eggermont; J Souffriau; F Van Hauwermeiren; M Willart; E Van Wonterghem; T Naessens; M Ballegeer; S Vandevyver; H Hammad; B Lambrecht; K De Bosscher; J Grooten; C Libert
Journal:  Mucosal Immunol       Date:  2015-03-11       Impact factor: 7.313

8.  Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections.

Authors:  P Mastroeni; J N Skepper; C E Hormaeche
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Authors:  D Gosselin; J DeSanctis; M Boulé; E Skamene; C Matouk; D Radzioch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.